Shares of Sarepta Therapeutics Inc (NASDAQ:SRPT) are finally waking up. This stock has been forgotten by momentum biotech investors ever since the rhetoric began to curb drug pricing. That appears to be changing. Sarepta Therapeutics is moving higher today, trading above the $30 key level. More importantly, the stock has broken a major resistance point which gives it free range to surge as high as $39 and maybe revisit $60 on positive drug news. This is a big deal because this stock has been a big mover in the past. On one day in September 2016, Sarepta Therapeutics jumped from $28 to $56, a 100% surge. This should give investors an idea why it is important to keep watch and potentiallly buy this breakout.



Shares of Sarepta Therapeutics breakout on the stock chart